Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesRohina Joshi, Anthony Rodgers, Bryan Williams et al.|New England Journal of Medicine|2008Cited by 7.4k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter Sever, Jan Östergren, Björn Dahlöf et al.|The Lancet|2003Cited by 3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Jan Östergren, Peter Sever et al.|The Lancet|2005Cited by 2.9k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, M. Angelyn Bethel et al.|New England Journal of Medicine|2017Cited by 2.1k
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Richard Peto, Christina Reith et al.|The Lancet|2016Cited by 1.8k